Stage IV Esophagus Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Stage IV Esophagus Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer (NCT05322499) | Zhejiang Cancer Hospital | 2022-04-15 |
Track Stage IV Esophagus Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.